<DOC>
	<DOCNO>NCT02850185</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness oxyhydrogen generator nebulizer adjuvant therapy severe COPD patient stable phase .</brief_summary>
	<brief_title>Adjuvant Therapy Severe COPD Patients Stable Phase Oxyhydrogen Generator With Nebulizer</brief_title>
	<detailed_description>In study , severe COPD patient stable phase include treatment control group , administer randomly oxyhydrogen generator nebulizer ( treatment group ) oxygen Nebulizer Machine （control group ）for adjuvant therapy . The therapeutic outcome treatment control group analyze evaluated verify safety effectiveness test product.This study multi-center , randomize , double-blind study . The trial last 3 month . The curative effect observe subject second week , first month , second month third month respectively observing time point . Total patient plan include 140 case , , 70 case treatment group control group respectively distribute 5 clinical hospital .</detailed_description>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>1 . It conform diagnostic criterion chronic obstructive pulmonary disease ( COPD ) : ( PFT ) The percentage force expiratory volume force vital capacity one second inhaling vasodilator ( FEV1 / FVC % &lt; 70 % ) ; 2 . Classification COPD severity pulmonary function : The criterion study Severe : FEV1/FVC &lt; 0.70 , FEV1 &lt; 50 % expect value pulmonary function examine take bronchodilator . 3 . More 40 year old normal ability judge independently ; men woman limit ; 4 . Living vicinity test centre past six month ; 1 ) Those acute exacerbation past 4 week ; 2 ) Lung disease history : Excluding history lung diseases except combine COPD , combine pulmonary tuberculosis diffuse pancapillary bronchiolitis , pneumonia , pneumothorax , pleural effusion , pulmonary embolism , etc . 3 ) Those suffer infectious disease hepatitis A , hepatitis B , AIDS tuberculosis connective tissue disease active period ; 4 ) Those suffer high fever , well various local systemic infection ( include respiratory , urinary reproductive system , digestive system , sepsis , etc . ) , severe infection , especially lung infection find CT examination ; 5 ) Those limited ability understand poor compliance ; legal capacity limit legal capacity ; participate clinical trial first 3 month include group ; mental physical disability ; 6 ) Those difficult make exact evaluation safety effectiveness product ; 7 ) The woman pregnancy lactation , well woman childbearing age n't agree take effective contraceptive measure study period ; 8 ) Those abnormal heart function thrombophlebitis ; 9 ) Those know ca n't stand oxygen hydrogen inhalation ; 10 ) Those suffered primary disease important visceral organ system , stroke , severe hypertension , gastric ulcer , uncontrolled diabetes , malignant tumor , liver kidney failure , severe heart disease history ( acute myocardial infarction , congestive heart failure heart diseases acute phase ) ; 11 ) Cancer progressive stage well undetermined mass find treatment ; 12 ) Those one lobectomy history ; 13 ) Those suspect really alcohol drug abuse history ; 14 ) Those whose AST ALT≥120U/L , Ccr≤50ml/min ; shock unstable hemodynamics ; 15 ) Those consider participate clinical trial investigator .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>hydrogen</keyword>
</DOC>